爱博医疗：拟通过并购贷款及自有资金收购德美医疗不低于51%股权，并取得控制权

Core Viewpoint - Aibo Medical has signed a letter of intent to acquire at least 51% of Demai Medical's shares to gain control, aiming to cultivate new profit growth points in the sports medicine sector [1] Group 1: Acquisition Details - The acquisition will be financed through a combination of acquisition loans and the company's own funds [1] - The transaction does not constitute a related party transaction or a major asset restructuring [1] Group 2: Company and Industry Insights - Demai Medical is recognized as a national high-tech enterprise and a "specialized, refined, and innovative" small giant, holding 276 patented technologies [1] - The products of Demai Medical cover the entire field of sports health, indicating a strong market position in a high-potential niche [1]